@inbook{a4cbae680d2c46359c3bf6a91595271e,
title = "Miscellaneous antibacterial drugs",
abstract = "This review of the January 2018 to December 2018 publications on miscellaneous antibacterial drugs covers aminoglycosides (amikacin and gentamicin), fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin and ofloxacin), glycopeptides (dalbavancin, teicoplanin and vancomycin), lincosamides (clindamycin), macrolides (azithromycin, clarithromycin, erythromycin and roxithromycin), oxazolidinones (tedizolid and linezolid), polymixins (colistin and polymyxin B), trimethoprim, trimethoprim–sulfamethoxazole, daptomycin, fosfomycin and fusidic acid.",
keywords = "Aminoglycosides, Clindamycin, Daptomycin, Fluoroquinolones, Fosfomycin, Fusidic acid, Glycopeptides, Macrolides, Oxazolidinones, Polymyxins, Trimethoprim–sulfamethoxazole",
author = "Tucker, {Emily C.} and Jessica Gehlert and Thynne, {Tilenka R.J.}",
year = "2019",
doi = "10.1016/bs.seda.2019.08.006",
language = "English",
isbn = "9780128171639",
volume = "41",
series = "Side Effects of Drugs Annual",
publisher = "Elsevier B.V.",
pages = "269--284",
editor = "Ray, {Sidhartha D.}",
booktitle = "Side Effects of Drugs Annual",
address = "Netherlands",
}